Immunomodulatory Effects of Multi-Strain Probiotic Capsules for Psoriatic Arthritis: A Pilot Double-Blind Randomized Controlled Trial.
Ontology highlight
ABSTRACT: Psoriatic arthritis (PsA) is characterized by joint inflammation and is frequently associated with psoriasis. Gut dysbiosis has been implicated in PsA pathogenesis, raising interest in probiotics as potential immunomodulatory agents. In a pilot, double-blind, randomized, placebo-controlled trial, 14 adults aged 18-60 years with mild-to-moderate psoriatic arthritis (PsA; Disease Activity in Psoriatic Arthritis [DAPSA] < 28) were randomized to receive either probiotic capsules or placebo daily for 12 weeks. The probiotic group received a multi-strain cocktail with a total concentration of 1 × 109 CFU (including Lactobacillus rhamnosus, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus helveticus, Lactobacillus acidophilus, Bifidobacterium bifidum, Lactobacillus bulgar
SUBMITTER: Alshihmani AHH
PROVIDER: S-EPMC12588955 | biostudies-literature | 2025 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA